BIOMAT Database Logo BIOMAT Database Logo

Labetolol in patients with hypertension and varying degrees of renal impairment. 1984

E G Breen, and M Lombard, and A Watson, and J A Keogh

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E G Breen, and M Lombard, and A Watson, and J A Keogh
Nabumetone pharmacokinetics in patients with varying degrees of renal impairment.
October 1987, The American journal of medicine,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Pharmacokinetics of vildagliptin in patients with varying degrees of renal impairment.
September 2013, International journal of clinical pharmacology and therapeutics,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
January 1991, International journal of clinical pharmacology research,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
April 1994, Clinical pharmacology and therapeutics,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.
June 2018, Journal of clinical pharmacology,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment.
November 2023, Antimicrobial agents and chemotherapy,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment.
June 2015, European journal of clinical pharmacology,
E G Breen, and M Lombard, and A Watson, and J A Keogh
A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairment.
January 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.
February 1998, Journal of clinical pharmacology,
E G Breen, and M Lombard, and A Watson, and J A Keogh
Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function.
February 1977, International journal of clinical pharmacology and biopharmacy,
Copied contents to your clipboard!